HAROLD SHINE to Simplexvirus
This is a "connection" page, showing publications HAROLD SHINE has written about Simplexvirus.
Connection Strength
0.304
-
Neurotoxicity of intracerebral injection of a replication-defective adenoviral vector in a semipermissive species (cotton rat). Gene Ther. 1997 Apr; 4(4):275-9.
Score: 0.138
-
Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors. Mol Ther. 2000 Feb; 1(2):195-203.
Score: 0.042
-
Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: pathologic, radiologic, and molecular studies. Hum Gene Ther. 1996 Jun 20; 7(10):1241-50.
Score: 0.033
-
Adenovirus-mediated gene therapy in an experimental model of breast cancer metastatic to the brain. Hum Gene Ther. 1995 Oct; 6(10):1317-22.
Score: 0.031
-
Adenovirus-mediated gene therapy for experimental spinal cord tumors: tumoricidal efficacy and functional outcome. Brain Res. 1995 Sep 11; 691(1-2):76-82.
Score: 0.031
-
Adenovirus-mediated gene therapy of experimental gliomas. J Neurosci Res. 1994 Nov 01; 39(4):506-11.
Score: 0.029